国际简称:PHARMACOEPIDEM DR S 参考译名:药物流行病学和药物安全
主要研究方向:医学-药学 非预警期刊 审稿周期: 约3月
《药物流行病学和药物安全》(Pharmacoepidemiology And Drug Safety)是一本由John Wiley and Sons Ltd出版的以医学-药学为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊,近三年没有被列入预警名单。
The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.
Particular areas of interest include:
design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;
comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;
methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;
assessments of harm versus benefit in drug therapy;
patterns of drug utilization;
relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;
evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.
CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||
4.8 | 1.106 | 1 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | PHARMACOLOGY & PHARMACY 药学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 | 4区 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 PHARMACOLOGY & PHARMACY 药学 | 3区 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 PHARMACOLOGY & PHARMACY 药学 | 3区 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 3区 | PHARMACOLOGY & PHARMACY 药学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 | 3区 3区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 PHARMACOLOGY & PHARMACY 药学 | 3区 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 3区 | PHARMACOLOGY & PHARMACY 药学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 | 3区 3区 |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 188 / 354 |
47% |
学科:PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SCIE | Q2 | 163 / 403 |
59.7% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 192 / 354 |
45.9% |
学科:PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SCIE | Q3 | 215 / 403 |
46.77% |
Author: Sun, Cuicui; Zhao, Lixia; Yuan, Yujie; Xiang, Yanxiao; Liu, Anchang
Journal: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023; Vol. 32, Issue 4, pp. 416-425. DOI: 10.1002/pds.5559
Author: Hung, Eric; Hauben, Manfred; Essex, Henry; Zou, Chen; Bright, Steve
Journal: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023; Vol. 32, Issue 3, pp. 387-391. DOI: 10.1002/pds.5555
Author: Hidayat, Khemayanto; Zhou, Ying-Yi; Du, Hong-Zhen; Qin, Li-Qiang; Shi, Bi-Min; Li, Zeng-Ning
Journal: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023; Vol. 32, Issue 2, pp. 107-125. DOI: 10.1002/pds.5550
Author: Lu, Li; Contrand, Benjamin; Schweitzer, Cedric; Gadegbeku, Blandine; Delcourt, Cecile; Lagarde, Emmanuel
Journal: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023; Vol. 32, Issue 5, pp. 535-544. DOI: 10.1002/pds.5577
Author: Jiang HY1, Zhang X1, Jiang CM2, Fu HB3.
Journal: Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):288-295. doi: 10.1002/pds.4716. Epub 2018 Dec 26.
Author: Li H1,2, Deng J3, Deng L3, Ren X2, Xia J1.
Journal: Pharmacoepidemiol Drug Saf. 2019 May 27. doi: 10.1002/pds.4805. [Epub ahead of print]
Author: Liu X, Liew Z, Olsen J, Pedersen LH, Bech BH, Agerbo E, Yuan W, Li J.
Journal: Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):188-95. doi: 10.1002/pds.3940. Epub 2015 Dec 16.
Author: Zhang D, Yan MX, Ma J, Xia W, Xue RH, Sun J, Zhang J.
Journal: Pharmacoepidemiol Drug Saf. 2016 Jan 8. doi: 10.1002/pds.3946. [Epub ahead of print]
Biomedicine & Pharmacotherapy
中科院 2区 JCR Q1
Frontiers In Pharmacology
中科院 2区 JCR Q1
Frontiers In Public Health
中科院 3区 JCR Q2
Bmc Psychiatry
中科院 2区 JCR Q2
Bmc Neurology
中科院 3区 JCR Q3
Bmc Womens Health
中科院 3区 JCR Q2
Bmc Public Health
中科院 2区 JCR Q1
Social Science & Medicine
中科院 2区 JCR Q1
若用户需要出版服务,请联系出版商:JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ。